Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease
scientific article published on 20 June 2011
Author/s
author: David Dingli, Angela Dispenzieri, Martha Q Lacy, Stephen J. Russell, S. Vincent Rajkumar, Morie A Gertz, Suzanne R Hayman, Steven R Zeldenrust, John A. Lust, Francis K Buadi, Shaji K Kumar, P Leif Bergsagel, Craig B Reeder, Vivek Roy, Joseph Mikhael, Philip R. Greipp, Kristen E Detweiler Short, Jacob B Allred, Kristina M Laumann, Rafael Fonseca
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.